Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Immunogenicity & safety study of GSK Biologicals’ 208136 vaccine formulated with new measles and rubella working seeds
Combined Measles, Mumps, Rubella, Varicella Vaccine
108760
NCT00892775
Measles; Mumps; Rubella; Varicella
Phase 2
 
An annotated case report form is not available for this study. A blank case report form will be provided.
February 2015

Powered by ideaPoint, Inc.